The entire Placebo (Rett) trial design logic(oversight) was a massive(dumb) move. Should never have happened, IMO. A DO-OVER is imperative. It cannot be left hanging over our collective heads as is. This should/must be a TOP AVXL management priority.
Missling said that he was going to discuss the path forward with the regulators. That sounds like continuing to pursue Rett to me.
The FDA is going to tell Anavex what the path forward will be. Until Anavex has that guidance from the FDA it is in a holding pattern vis a vis Rett